-
FLXN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Flexion Therapeutics (FLXN)
Company Profile
Quarter (USD) | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 136.82 mm | 136.82 mm | 136.82 mm | 136.82 mm | 136.82 mm | 136.82 mm |
Cash burn (monthly) | (no burn) | (no burn) | 10.10 mm | 8.39 mm | 4.74 mm | 5.10 mm |
Cash used (since last report) | n/a | n/a | 415.09 mm | 344.83 mm | 194.52 mm | 209.46 mm |
Cash remaining | n/a | n/a | -278.27 mm | -208.00 mm | -57.70 mm | -72.64 mm |
Runway (months of cash) | n/a | n/a | -27.5 | -24.8 | -12.2 | -14.2 |
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 18.14 mm |
Total shares | 1.39 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Versant Venture Capital III | 1.39 mm | $18.14 mm |